Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 451

1.

Treatment of chronic autoimmune urticaria with omalizumab.

Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK.

J Allergy Clin Immunol. 2008 Sep;122(3):569-73. doi: 10.1016/j.jaci.2008.07.006.

PMID:
18774392
2.

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.

Maurer M, Altrichter S, Bieber T, Biedermann T, Bräutigam M, Seyfried S, Brehler R, Grabbe J, Hunzelmann N, Jakob T, Jung A, Kleine-Tebbe J, Mempel M, Meurer M, Reich K, Ruëff F, Schäkel K, Sengupta K, Sieder C, Simon JC, Wedi B, Zuberbier T, Mahler V, Staubach P.

J Allergy Clin Immunol. 2011 Jul;128(1):202-209.e5. doi: 10.1016/j.jaci.2011.04.038. Epub 2011 Jun 2.

PMID:
21636116
3.
4.

Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab).

Milgrom H, Berger W, Nayak A, Gupta N, Pollard S, McAlary M, Taylor AF, Rohane P.

Pediatrics. 2001 Aug;108(2):E36.

PMID:
11483846
5.

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.

Saini S, Rosen KE, Hsieh HJ, Wong DA, Conner E, Kaplan A, Spector S, Maurer M.

J Allergy Clin Immunol. 2011 Sep;128(3):567-73.e1. doi: 10.1016/j.jaci.2011.06.010. Epub 2011 Jul 18.

PMID:
21762974
6.

Effect of omalizumab on patients with chronic urticaria: issues with the determination of autoimmune urticaria.

Sheikh J.

Ann Allergy Asthma Immunol. 2008 Jan;100(1):88; author reply 88-9. doi: 10.1016/S1081-1206(10)60412-7. No abstract available.

PMID:
18254490
7.

Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria.

Sabroe RA, Francis DM, Barr RM, Black AK, Greaves MW.

J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):651-8.

PMID:
9802375
8.

Basophil CD63 expression assay on highly sensitized atopic donor leucocytes-a useful method in chronic autoimmune urticaria.

Gyimesi E, Sipka S, Dankó K, Kiss E, Hídvégi B, Gál M, Hunyadi J, Irinyi B, Szegedi A.

Br J Dermatol. 2004 Aug;151(2):388-96.

PMID:
15327546
9.

Omalizumab: a review of its use in patients with chronic spontaneous urticaria.

McCormack PL.

Drugs. 2014 Sep;74(14):1693-9. doi: 10.1007/s40265-014-0290-9. Review.

PMID:
25217402
10.

Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils.

Lin H, Boesel KM, Griffith DT, Prussin C, Foster B, Romero FA, Townley R, Casale TB.

J Allergy Clin Immunol. 2004 Feb;113(2):297-302.

PMID:
14767445
11.

Effect of omalizumab on patients with chronic urticaria.

Spector SL, Tan RA.

Ann Allergy Asthma Immunol. 2007 Aug;99(2):190-3.

PMID:
17718108
12.

[Chronic autoimmune urticaria: treatment with omalizumab].

Máspero JF, Parisi CA, De Gennaro M, Benhabib O, Lampert M.

Arch Argent Pediatr. 2009 Oct;107(5):452-6. doi: 10.1590/S0325-00752009000500014. Spanish.

13.

Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge.

Eckman JA, Sterba PM, Kelly D, Alexander V, Liu MC, Bochner BS, Macglashan DW Jr, Saini SS.

J Allergy Clin Immunol. 2010 Apr;125(4):889-895.e7. doi: 10.1016/j.jaci.2009.09.012. Epub 2009 Dec 4.

14.

Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation.

Macglashan DW Jr, Saini SS.

J Allergy Clin Immunol. 2013 Oct;132(4):906-11.e1-4. doi: 10.1016/j.jaci.2013.04.056. Epub 2013 Jun 20.

15.

Mechanisms of autoimmune activation of basophils in chronic urticaria.

Kikuchi Y, Kaplan AP.

J Allergy Clin Immunol. 2001 Jun;107(6):1056-62.

PMID:
11398085
16.

Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema.

Altman K, Chang C.

Clin Rev Allergy Immunol. 2013 Aug;45(1):47-62. doi: 10.1007/s12016-012-8326-y. Review.

PMID:
22674016
17.

Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria.

Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW.

N Engl J Med. 1993 Jun 3;328(22):1599-604.

18.

The autoimmune nature of chronic urticaria.

Boguniewicz M.

Allergy Asthma Proc. 2008 Sep-Oct;29(5):433-8. doi: 10.2500/aap.2008.29.3148. Review.

PMID:
18926050
19.

Pathogenesis of chronic urticaria.

Kaplan AP, Greaves M.

Clin Exp Allergy. 2009 Jun;39(6):777-87. doi: 10.1111/j.1365-2222.2009.03256.x. Epub 2009 Apr 22. Review.

PMID:
19400905
20.

Omalizumab may not inhibit mast cell and basophil activation in vitro.

Gericke J, Ohanyan T, Church MK, Maurer M, Metz M.

J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1832-6. doi: 10.1111/jdv.12693. Epub 2014 Sep 26. Review.

PMID:
25257818
Items per page

Supplemental Content

Write to the Help Desk